Genetics: APOC3 mutations lower CVD risk

Nature Reviews Cardiology

Volumn 11, Issue 9, 2014, Pages 496-

  Geach, Tim ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN C3; LIPOPROTEIN; TRIACYLGLYCEROL;

APOC3 GENE; CARDIOVASCULAR RISK; EXON; FRAMINGHAM RISK SCORE; GENE; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; ISCHEMIC HEART DISEASE; NOTE; PRIORITY JOURNAL; RISK REDUCTION; TRIACYLGLYCEROL BLOOD LEVEL;

APOLIPOPROTEIN C-III; CORONARY DISEASE; FEMALE; HUMANS; ISCHEMIA; MALE; MUTATION; MYOCARDIAL ISCHEMIA; TRIGLYCERIDES;

EID: 84906933638     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/nrcardio.2014.99     Document Type: Note

References (2)

1. Jø rgensen, A. B. et al. Loss-of-function mutations in APOC3 and risk of ischemic vascular disease. N. Engl. J. Med. doi:10.1056/NEJMoa1308027
2. The TG and HDL Group of the Exome Sequencing Project, National Heart, Lung, and Blood Institute. Loss-of-function mutatio ns in APOC3, triglycerides, and coronary heart disease. N. Engl. J. Med. doi:10.1056/NEJMoa1307095